SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-16-001874
Filing Date
2016-03-02
Accepted
2016-03-02 17:54:20
Documents
2
Period of Report
2016-03-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 4524
2 POWER OF ATTORNEY egrospoa.htm EX-24 6200
  Complete submission text file 0001123292-16-001874.txt   12125
Mailing Address 460 TOTTEN POND ROAD SUITE 650 WALTHAM MA 02451
Business Address 460 TOTTEN POND ROAD SUITE 650 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Issuer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. TOTTEN POND ROAD, SUITE 140 WALTHAM MA 02451
Business Address
Egros Fabrice (Reporting) CIK: 0001597085 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37708 | Film No.: 161478694